1. Academic Validation
  2. Arimistane: Degradation product or metabolite of 7-oxo-DHEA?

Arimistane: Degradation product or metabolite of 7-oxo-DHEA?

  • Drug Test Anal. 2021 Jul;13(7):1430-1439. doi: 10.1002/dta.3036.
Dayamín Martínez Brito 1 Patrizia Leogrande 1 Cristiana Colamonici 1 Davide Curcio 1 Francesco Botre 1 2 Xavier de la Torre 1
Affiliations

Affiliations

  • 1 Laboratorio Antidoping FMSI, Rome, Italy.
  • 2 REDs-Research and Expertise on Anti-Doping Sciences, Institute of Sport Science, University of Lausanne (ISSUL), Lausanne, Switzerland.
Abstract

Rationale: The instability of androst-5-ene-3,7-dione structures under acidic conditions is known. The formation of arimistane from 7-oxo-DHEA, influenced by the conditions of sample extraction, and mainly derivatization reaction and gas chromatography (GC) injector temperature, was described earlier, potentially leading to misinterpretation of results. By using a liquid chromatography (LC)-mass spectrometry (MS) (LC-MS) we investigated the stability of the 7-oxo-DHEA in two different Solvents (methanol and dimethyl sulfoxide [DMSO]), and the arimistane formation after the application common analytical procedures. Additionally, in vitro and in vivo studies of 7-oxo-DHEA were performed.

Methods: The stability of 7-oxo-DHEA was studied in solutions after 60 days storage at -20°C. In vitro studies were performed by incubating 7-oxo-DHEA with human liver microsomes (HLMs). Healthy volunteers collected urine samples before and after the administration of a single dose of 7-oxo-DHEA. Analyses were performed using high-performance LC (HPLC) coupled to a triple quadrupole mass spectrometer (MS/MS) and GC combustion isotope ratio mass spectrometry (GC-C-IRMS) following HPLC purification.

Results: 7-oxo-DHEA was stable after 60 days in DMSO while a protic solvent as methanol promotes the degradation of 7-oxo-DHEA to arimistane. HLM incubations showed no formation of arimistane and the sample preparation only influenced the degradation of 7-oxo-DHEA when solvolysis was applied. After the administration study the presence of arimistane also after the hydrolysis with β-glucuronidase (Escherichia coli) was observed while using β-glucuronidase/arylsulfatase (Helix pomatia) showed the presence of arimistane already in blank samples collected before administration.

Conclusions: Our results confirm arimistane as a valuable diagnostic marker of 7-oxo-DHEA administration, but also indicate that its formation is due to degradation processes rather than to metabolic biotransformation reactions.

Keywords

7-oxo-DHEA; arimistane; degradation product; liquid chromatography-mass spectrometry; metabolism.

Figures
Products